Evaluation of recombinant human erythropoietin to facilitate autologous blood donation before surgery in anaemic patients with cancer of the gastrointestinal tract

British Journal of Surgery

Volumn 82, Issue 12, 1995, Pages 1637-1640

  Braga, M ^a   Gianotti, L ^a   Vignali, A ^a   Gentilini, O ^a   Servida, P ^a   Bordignon, C ^a   Di Carlo, V ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; BLOOD AUTOTRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ADULT; AGED; ANEMIA, IRON-DEFICIENCY; BLOOD TRANSFUSION, AUTOLOGOUS; COLONIC NEOPLASMS; ERYTHROPOIETIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; RECTAL NEOPLASMS; STOMACH NEOPLASMS;

EID: 0028882041     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.1800821216     Document Type: Article

References (32)

1. Association between perioperative blood transfusion and postoperative infection in patients having elective operations for gastrointestinal cancer
2. Perioperative blood transfusion associated with infectious complications after colo‐rectal cancer operations
3. Blood transfusion infectious complications following colo‐rectal cancer surgery
4. Mechanisms of transfusion‐induced immunosuppression
5. Transfusion and recipient immune function
6. Beneficial effect of pre‐transplant donorspecific transfusions: evidence for an idiotype network mechanism
7. Prostaglandin production and suppressor cell induction in transfusion‐induced immune‐suppression
8. Impact of a programme of autologous blood donation on the incidence of infection in patients with colorectal cancer
9. Decreased erythropoietin response in patients with the anemia of cancer
10. Anaemia in rheumatoid arthritis: pathogenesis, diagnosis and treatment
11. Progress in understanding the pathogenesis of the anemia of the chronic disease
12. Erythropoietin
13. Sickle cell anemia patients have low erythropoietin levels for their degree of anemia
14. Serum immunoreactive erythropoictin in HIV infected patients
15. Recombinant human erythropoietin for patients with AIDS treated with zidovudme
16. Recombinant human ervthropoietin and autologous blood donation
17. Recombinant human erythropoietin corrects anemia of blood loss: a study in the dog
18. Effect of preoperative recombinant human erythropoietin on postoperative erythropoiesis
19. Erythropoietin and autologous blood donation
20. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy
21. Preoperative erythropoietin in Jehovah's Witnesses who require cardiac procedures
22. Autologous blood transfusion with recombinant human erythropoietin in heart operations
23. Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients
24. Preoperative red cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy
25. A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy
26. Recombinant human erythropoietin and its role in transfused medicine
27. Erythropoietin deficiency: a complication of cisplatin therapy and its treatment with recombinant human erythropoietin
28. Recombinant human erythropoietin accelerates recovery from cisplatin induced anemia in cancer patients: preliminary results
29. Recombinant human erythropoietin in patients with ovarian carcinoma and anemia secondary to cisplatin and carboplatin chemotherapy: preliminary results
30. Association between transfusion of whole blood and recurrence of cancer
31. Blood transfusion and postoperative septic complications
32. Blood transfusion and prognosis in colo‐rectal cancer